Announcements Trials
Browse Landscape

Phase

Phase 3 90Phase 2 63Phase NA 38Phase 1 11Phase 1/2 9Phase EARLY_PHASE1 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 91INDUSTRY 20OTHER_GOV 4UNKNOWN 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lymphoma 4Colorectal Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Xerostomia 1Warts 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stomach Neoplasms 1Sezary Syndrome 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non-Small Cell Lung Cancer 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain 1

Interventions

Vinorelbine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Breast Neoplasms × Clear all
NCT00049660 2012-07-18

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
47 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡